Core Viewpoint - The company has reached a consensus on international development, prioritizing "going global" as a key strategic direction and has formed a dedicated exploration team [1] Group 1: International Expansion Strategy - The company plans to initially focus on expanding its chicken business internationally, with future plans to gradually extend to pig and duck industries [1] - The company is leveraging its years of overseas experience and channel resources in animal health, agricultural equipment, and environmental protection to explore international markets [1] Group 2: Market Engagement - The company has initiated preliminary discussions with enterprises and government departments in countries such as Vietnam, Malaysia, India, and South Korea [1] - Various cooperation models are being explored, including product trade exports, technology output, and joint ventures for factory establishment [1] Group 3: Market Potential - The company believes that the global demand for livestock and poultry products is continuously growing, indicating a vast overseas market with long-term strategic value [1]

格隆汇2月5日丨温氏股份(300498.SZ)公布，公司的全资子公司广东温氏投资有限公司（简称"温氏投 资"）拟以自有资金受让青岛双安生物科技有限公司（简称"青岛双安"、"标的公司"）的部分股权并向 其进行增资，公司关联方温润农科壹号（珠海）创业投资基金合伙企业（有限合伙）（简称"农科壹 号"）是青岛双安的现有股东并计划转让其持有的股权，本次股权投资构成关联交易。温氏投资本次拟 投资金额不超过14,725万元；其中，受让农科壹号持有股权的交易金额为1,997.3369万元。 ...

格隆汇2月5日丨温氏股份(300498.SZ)公布，公司的全资子公司广东温氏投资有限公司（简称"温氏投 资"）拟与公司关联方暨专业投资机构温润农业生物科技（云南）创业投资基金合伙企业（有限合伙） （简称"温润农业生物基金"）、温润安享科盈（海南）股权投资基金合伙企业（有限合伙）（简称"温 润安享"）、专业投资机构滨州智空创业投资基金合伙企业（有限合伙）（简称"滨州智空基金"）等共 同投资山东恒鑫生物科技有限公司（简称"恒鑫生物"、"标的公司"），温氏投资本次拟以自有资金出资 不超过20,500万元。 ...

格隆汇2月5日丨温氏股份(300498.SZ)公布，公司2026年1月销售肉鸡11,169.71万只（含毛鸡、鲜品和熟 食），收入29.73亿元，毛鸡销售均价11.72元/公斤，环比变动分别为2.24%、-3.13%、-9.50%，同比变 动分别为18.03%、25.50%、2.81%。 公司2026年1月销售肉猪296.36万头（含毛猪和鲜品），收入46.98亿元，毛猪销售均价12.75元/公斤， 环比变动分别为-35.05%、-11.17%、9.91%，同比变动分别为2.20%、-12.17%、-19.15%。 ...

Core Viewpoint - The announcement from Wens Foodstuff Group indicates a mixed performance in sales and revenue for January 2026, with notable changes in both chicken and pork product sales [1] Group 1: Chicken Sales - In January 2026, the company sold 112 million chickens (including live chickens, fresh products, and cooked food), generating revenue of 2.973 billion yuan [1] - The average selling price for live chickens was 11.72 yuan per kilogram, with a month-on-month change of 2.24% and a year-on-year change of 18.03% [1] - The sales volume of white feather chicken seedlings reached 13.1095 million [1] Group 2: Pork Sales - The company sold 2.9636 million pigs (including live pigs and fresh products) in January 2026, resulting in revenue of 4.698 billion yuan [1] - The average selling price for live pigs was 12.75 yuan per kilogram, with a month-on-month change of -35.05% and a year-on-year change of 2.20% [1] - The revenue from pork sales showed a month-on-month decline of 11.17% and a year-on-year decline of 12.17% [1]

每经AI快讯，温氏股份2月5日晚间发布公告称，公司第五届第十二次董事会会议于2026年2月5日在总 部一楼会议室以现场结合通讯表决的方式召开。会议审议了《关于子公司股权投资暨关联交易的议案》 等文件。 （记者 张明双） 每经头条（nbdtoutiao）——仅老年独居者就数千万，谁能帮他们从容老去？意定监护在国内诞生已14 年，距全面落地还差"最后一公里" ...

Core Viewpoint - The company plans to invest up to 205 million yuan in Shandong Hengxin Biotechnology Co., Ltd. through its wholly-owned subsidiary, Guangdong Wens Investment Co., Ltd. This investment is primarily focused on equity investment and does not involve direct business operations, thus avoiding any competition or related transactions with its main business [1] Group 1 - The investment will be made in collaboration with affiliated and professional investment institutions, including Wensrun Agricultural Biotechnology (Yunnan) Venture Capital Fund and Binzhou Zhikong Venture Capital Fund [1] - The investment amount is capped at 205 million yuan, which is approximately 30 million USD [1] - The investment target, Hengxin Biotechnology, operates in a different sector from the company's main business, ensuring no conflict of interest arises [1]

本次对恒鑫生物的投资不涉及经营具体业务，主要以股权投资为主，投资目标与公司主营业务不同，不 会导致同业竞争或关联交易。 智通财经APP讯，温氏股份(300498.SZ)公告，公司全资子公司广东温氏投资有限公司("温氏投资")拟与 公司关联方暨专业投资机构温润农业生物科技(云南)创业投资基金合伙企业(有限合伙)("温润农业生物 基金")、温润安享科盈(海南)股权投资基金合伙企业(有限合伙)("温润安享")、专业投资机构滨州智空创 业投资基金合伙企业(有限合伙)("滨州智空基金")等共同投资山东恒鑫生物科技有限公司("恒鑫生物")， 温氏投资本次拟以自有资金出资不超过2.05亿元。 ...

温氏股份2月5日晚间公告，公司2026年1月销售肉鸡11,169.71万只（含毛鸡、鲜品和熟食），收入29.73 亿元，毛鸡销售均价11.72元/公斤，环比变动分别为2.24%、-3.13%、-9.50%，同比变动分别为18.03%、 25.50%、2.81%。 ...

温氏股份公告，2026年1月销售肉猪296.36万头（含毛猪和鲜品），收入46.98亿元，毛猪销售均价12.75 元/公斤，环比变动分别为-35.05%、-11.17%、9.91%，同比变动分别为2.20%、-12.17%、-19.15%。 ...